(secondQuint)Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making.

 The study is a non-randomized clinical trial.

 The protocol has been approved by the Ethics Committee of Beijing Cancer Hospital.

 MRI and enhanced CT are used to evaluate the clinical response of the tumor.

 The primary endpoint is the maximal cycle of effective neoadjuvant chemotherapy for resectable gastric cancer.

.

 Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making@highlight

The purpose of the study is to evaluate the maximal cycle of effective neoadjuvant chemotherapy for resectable gastric cancer, to determine what is the best cycle of neoadjuvant chemotherapy for the patients who receive neoadjuvant chemotherapy.

